Scottsdale Healthcare-TGen Clinical Trial Results Signal Advances Against Skin Cancer

Analyses of clinical trial results published in the New England Journal of Medicine (NEJM) shows a potential new investigational therapy for advanced and metastatic basal cell skin cancer. The study, conducted at TGen Clinical Research Service (TCRS) at Scottsdale Healthcare and two other sites appears to demonstrate tumor shrinkage and limited side effects.